Clinical Trials
27 trialsNaliCap
Seoul National University Hospital
Pembrolizumab Plus Chemotherapy in 1st Line Treatment of Pancreatic Cancer
Seoul National University Hospital
HOLIPANC
University of Cologne
Study of Immunotherapy Combined With Chemotherapy in Locally Advanced and Metastatic Pancreatic Cancer
Changhai Hospital
FOOTPATH
Ludwig-Maximilians - University of Munich
MASTERPLAN
Australasian Gastro-Intestinal Trials Group
FOLFIRINOX + RT for Pancreatic Cancer
Massachusetts General Hospital
Alternative Neoadjuvant Chemotherapy in Resectable and Borderline Resectable Pancreatic Cancer
Benaroya Research Institute
PanFLOX
Instituto do Cancer do Estado de São Paulo
Proton w/FOLFIRINOX-Losartan for Pancreatic Cancer
Massachusetts General Hospital
Implementation of Pre-emptive Geno- and Phenotyping in 5-Fluorouracil- or Capecitabine-treated Patients
Jessa Hospital
xenoZ
University of Pisa
A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies
Leaf Vertical Inc.
Folfirinox
McGill University Health Centre/Research Institute of the McGill University Health Centre
Neoadjuvant FOLFIRINOX Regimen in Patients With Non-metastatic Pancrease Cancer
Baylor Research Institute
Second-Line Adjuvant Therapy With Nab-Paclitaxel Plus Gemcitabine Versus Oxaliplatin Plus Folinic Acid and Fluorouracil for Gemcitabine-Refractory Pancreatic Cancer After Curative Resection
Fudan University
Biomarker Directed Adjuvant Chemotherapy for Resected Pancreas Cancer
AHS Cancer Control Alberta
Panc001
AHS Cancer Control Alberta
Internal Radiation Therapy With Y-90 Microspheres, External Radiation Therapy With Tomotherapy, and Fluorouracil in Treating Patients With Newly Diagnosed or Recurrent Pancreatic Cancer and Liver Metastases That Cannot Be Removed By Surgery
National Cancer Institute (NCI)
Nitrocamptothecin Compared With Other Chemotherapy in Treating Patients With Recurrent or Refractory Cancer of the Pancreas
National Cancer Institute (NCI)
Nitrocamptothecin or Fluorouracil in Treating Patients With Recurrent or Refractory Pancreatic Cancer
National Cancer Institute (NCI)
Fluorouracil, External-Beam Radiation Therapy, and Gemcitabine With or Without Brachytherapy Using Phosphorus P32 in Treating Patients With Locally or Regionally Advanced Unresectable Adenocarcinoma of the Pancreas
National Cancer Institute (NCI)
A Phase II Study of Locally Advanced Pancreatic Cancer
National Health Research Institutes, Taiwan
Fluorouracil Plus Radiation Therapy Following Surgery in Treating Patients With Pancreatic Cancer
National Cancer Institute (NCI)
Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas or Bile Duct
National Cancer Institute (NCI)
Gemcitabine and Oxaliplatin Followed By Radiation Therapy, Fluorouracil, and Oxaliplatin in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery
National Cancer Institute (NCI)
Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic Cancer
Seattle Cancer Treatment and Wellness Center